Spero Therapeutics Inc.

0.74
0.01 (1.77%)
At close: Apr 24, 2025, 12:38 PM

Spero Therapeutics Revenue

Spero Therapeutics reported an annual revenue of $47.98M, reflecting a -50.4% growth. For the quarter ending December 31, 2024, Spero Therapeutics generated $9.36M in revenue.
Revenue (ttm)
$47.98M
Revenue Growth
-50.4%
Price / Sales Ratio
1.16
Revenue / Employee
$1.5M
Employees
32
Market Cap
41.37M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 47.98M -50.40%
Dec 31, 2023 96.73M +99.13%
Dec 31, 2022 48.58M +166.10%
Dec 31, 2021 18.26M +95.67%
Dec 31, 2020 9.33M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.